Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.25
-0.2400-6.88%
Volume:391.89K
Turnover:1.28M
Market Cap:179.77M
PE:-2.88
High:3.47
Open:3.47
Low:3.21
Close:3.49
Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Voyager Therapeutics (VYGR), BioNTech SE (BNTX)

TIPRANKS
·
14 Nov 2024

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?

Simply Wall St.
·
14 Nov 2024

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Voyager Therapeutics: Promising Alzheimer’s Program and Strong Financial Position Support Buy Rating

TIPRANKS
·
14 Nov 2024

Voyager Therapeutics’ Innovative CNS Pipeline and Promising Alzheimer’s Developments Justify Buy Rating

TIPRANKS
·
14 Nov 2024

Q3 2024 Voyager Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Voyager Therapeutics Inc : Leerink Partners Cuts Target Price to $14 From $15

THOMSON REUTERS
·
13 Nov 2024

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com
·
13 Nov 2024

Voyager Therapeutics: Solid Financial Foundation and Strategic Progress Justify Buy Rating

TIPRANKS
·
13 Nov 2024

Voyager Therapeutics Reports Strong Q3 2024 Progress

TIPRANKS
·
13 Nov 2024

Voyager Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
13 Nov 2024

Voyager Therapeutics: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Voyager Therapeutics GAAP EPS of -$0.16 beats by $0.29, revenue of $24.63M beats by $12.93M

seekingalpha
·
13 Nov 2024

Voyager Therapeutics Q3 2024 GAAP EPS $(0.16) Beats $(0.46) Estimate, Sales $24.60M Beat $11.89M Estimate

Benzinga
·
13 Nov 2024

Voyager Reports Third Quarter 2024 Financial and Operating Results

GlobeNewswire
·
13 Nov 2024